Updating results

571 results

Sort: Relevance | Date

Hypertension in pregnancy: diagnosis and management (Update)

In development [GID-NG10083] Expected publication date: 25 June 2019

NICE guideline In development

Depression in children and young people: identification and management

In development [GID-NG10106] Expected publication date: 25 June 2019

NICE guideline In development

Reinforcement of permanent stomas with mesh to prevent parastomal hernias

In development [GID-IPG10105] Expected publication date: 26 June 2019

Interventional procedures guidance In development

Cardiac contractility modulation device implantation for heart failure

In development [GID-IPG10106] Expected publication date: 26 June 2019

Interventional procedures guidance In development

Transcatheter valve-in-valve implantation for the treatment of aortic bioprosthetic valve dysfunction

In development [GID-IPG10107] Expected publication date: 26 June 2019

Interventional procedures guidance In development

Nusinersen for treating spinal muscular atrophy ID1069

In development [GID-TA10281] Expected publication date: 26 June 2019

Technology appraisal guidance In development

Multiple myeloma (newly diagnosed) - lenalidomide [ID474]

In development [GID-TAG429] Expected publication date: 26 June 2019

Technology appraisal guidance In development

Multiple myeloma - lenalidomide (post bortezomib) (part rev TA171) [ID667]

In development [GID-TAG452] Expected publication date: 26 June 2019

Technology appraisal guidance In development

Dementia (update)

In development [GID-QS10079] Expected publication date: 28 June 2019

Quality standard In development

Abdominal aortic aneurysm: diagnosis and management

In development [GID-CGWAVE0769] Expected publication date: 03 July 2019

NICE guideline In development

Cemiplimab for treating cutaneous squamous cell carcinoma [ID1367]

In development [GID-TA10304] Expected publication date: 03 July 2019

Technology appraisal guidance In development

Pembrolizumab with carboplatin and paclitaxel for untreated squamous non-small-cell lung cancer [ID1306]

In development [GID-TA10245] Expected publication date: 04 July 2019

Technology appraisal guidance In development

Cabozantinib for treating advanced hepatocellular carcinoma after prior therapy [ID1243]

Technology appraisal [TA582] Published date: 24 May 2019

Technology appraisal guidance In development

Hearing loss (adult onset)

In development [GID-QS10074] Expected publication date: 10 July 2019

Quality standard In development

Lyme disease

In development [GID-QS10076] Expected publication date: 10 July 2019

Quality standard In development

Therapeutic monitoring of TNF-alpha inhibitors in rheumatoid arthritis

In development [GID-DG10022] Expected publication date: 10 July 2019

Diagnostics guidance In development

Maternal health

In development [GID-QS10077] Expected publication date: TBC

Quality standard In development

Neratinib for treating early hormone receptor-positive HER2-positive breast cancer after adjuvant trastuzumab [ID981]

In development [GID-TA10107] Expected publication date: 02 October 2019

Technology appraisal guidance In development

Avatrombopag and lusutrombopag for treating thrombocytopenia in people with chronic liver disease needing an elective procedure [ID1520]

In development [GID-TA10444] Expected publication date: 26 February 2020

Technology appraisal guidance In development

Intrapartum care: women with existing medical conditions or obstetric complications and their babies

In development [GID-QS10081] Expected publication date: 04 February 2020

Quality standard In development

Lorlatinib for treating ALK-positive advanced non-small-cell lung cancer [ID1338]

In development [GID-TA10317] Expected publication date: TBC

Technology appraisal guidance In development

Encorafenib with binimetinib and cetuximab for previously treated BRAF V600E mutation-positive metastatic colorectal cancer

In development [GID-TA10479] Expected publication date: 22 July 2020

Technology appraisal guidance In development

Fedratinib for splenomegaly and symptoms in myelofibrosis [ID1501]

In development [GID-TA10406] Expected publication date: TBC

Technology appraisal guidance In development

Selective internal radiation therapies for treating hepatocellular carcinoma ID1276

In development [GID-TA10381] Expected publication date: TBC

Technology appraisal guidance In development

Voretigene neparvovec for treating inherited retinal dystrophies caused by RPE65 gene mutations ID1054

In development [GID-HST10025] Expected publication date: 08 January 2020

Highly specialised technologies guidance In development

Internal air: health effects

In development [GID-QS10113] Expected publication date: 20 October 2020

Quality standard In development

Suspected neurological conditions

In development [GID-QS10082] Expected publication date: 03 July 2020

Quality standard In development

Workplace health: long-term sickness absence and management

In development [GID-QS10114] Expected publication date: 13 January 2021

Quality standard In development

Termination of pregnancy services

In development [GID-QS10084] Expected publication date: 18 August 2020

Quality standard In development

Elective joint replacement

In development [GID-QS10090] Expected publication date: 13 January 2021

Quality standard In development

Tobacco: preventing uptake, promoting quitting and treating dependence (update)

In development [GID-NG10086] Expected publication date: 16 January 2020

NICE guideline In development

Axicabtagene ciloleucel for treating relapsed or refractory mantle cell lymphoma ID1313

In development [GID-TA10312] Expected publication date: 09 December 2020

Technology appraisal guidance In development

Fetal surgery for open neural tube defects

In development [GID-IPG10120] Expected publication date: TBC

Interventional procedures guidance In development

Trifluridine–tipiracil for treating metastatic gastric or gastro-oesophageal junction cancer after 2 or more therapies [ID1507]

In development [GID-TA10456] Expected publication date: TBC

Technology appraisal guidance In development

Cellulitis and erysipelas: antimicrobial prescribing

In development [GID-NG10131] Expected publication date: 27 September 2019

Antimicrobial prescribing guideline In development

Atrial fibrillation: management

In development [GID-NG10100] Expected publication date: 17 September 2020

NICE guideline In development

Caesarean section (Update)

In development [GID-NG10081] Expected publication date: 10 November 2020

NICE guideline In development

Nivolumab in combination for untreated advanced gastric cancer [ID1465]

In development [GID-TA10352] Expected publication date: 10 June 2020

Technology appraisal guidance In development

Nivolumab for previously treated oesophageal cancer [ID1249]

In development [GID-TA10222] Expected publication date: 08 July 2020

Technology appraisal guidance In development

Nivolumab with radiation therapy for untreated glioblastoma ID1562

In development [GID-TA10443] Expected publication date: TBC

Technology appraisal guidance In development

Mogamulizumab for previously treated T-cell leukaemia-lymphoma [ID1390]

In development [GID-TA10464] Expected publication date: TBC

Technology appraisal guidance In development

Erdafitinib for treating metastatic or unresectable FGFR-positive urothelial cancer [ID1333]

In development [GID-TA10252] Expected publication date: TBC

Technology appraisal guidance In development

Volanesorsen for treating familial chylomicronaemia syndrome [ID1326]

In development [GID-HST10015] Expected publication date: TBC

Highly specialised technologies guidance In development

Peginterferon beta-1a for treating relapsing–remitting multiple sclerosis [ID1521]

In development [GID-TA10471] Expected publication date: TBC

Technology appraisal guidance In development

TYRX Absorbable Antibacterial Envelope for preventing infection from cardiac implantable electronic devices [ID1440]

In development [GID-TA10370] Expected publication date: 19 February 2020

Technology appraisal guidance In development

Palbociclib in combination with fulvestrant for treating advanced, hormone-receptor positive, HER2-negative breast cancer after endocrine therapy [ID916]

In development [GID-TA10095] Expected publication date: 18 December 2019

Technology appraisal guidance In development

Encorafenib with binimetinib and cetuximab for previously treated BRAF V600E mutation-positive metastatic colorectal cancer [ID1598]

In development [GID-TA10496] Expected publication date: TBC

Technology appraisal guidance In development

Nivolumab with ipilimumab for untreated unresectable malignant pleural mesothelioma [ID1609]

In development [GID-TA10498] Expected publication date: TBC

Technology appraisal guidance In development